Trophic serves as a strategic partner for all aspects of communications for life science companies. We apply a deep understanding of both the science and business of drug development and the capital needed for success. Based on breadth and depth of experience, Trophic has become the go-to advisory for presenting corporate stories and scientific concepts. Current client portfolio ranges from biotech start-ups, listed biopharmas and small and large pharmaceutical companies.

TROPHIC TWITTER FEED

Follow us on Twitter to stay tuned on biotech news and the inner workings of the Trophic team

August is #NationalImmunizationAwarenessMonth in the US. The pandemic has shown that it is more important than ever to get #vaccinated. Wondering which vaccines you & your loved ones should have to protect yourself? Check out the CDC's vaccine guide: https://t.co/dZ6Pa3OlH9

Introducing our brilliant Senior Account Executive, @Laura_Alice_M. With a PhD in #Immunooncology, she brings valuable scientific training & uses her passion for science to communicate advances for public & private #Biotech companies. #MeetTheTeam at https://t.co/oADEtaXct2

#HappyBirthday to our amazing Account Executive, @SophiaHergenhan! A multitasker equipped with a positive attitude & an endless supply of delicious (Paulaner) Spezi soda, there’s nothing this scientist & comms professional can’t do! #Cheers and #AllesGute on your special day! 🎉

Our client, Tenpoint Therapeutics emphasized having the right #PR agency by your side while exiting stealth mode in a Life Science Leader article. Trophic ensures strategically thought-out reveals that hone client messaging & convey unique value-adds.

Coming Out Of Stealth Mode: What To Know And Do

Five CEOs discuss their experiences with stealth mode transitions. They address when and how a company should turn away from that introspective state ...

www.lifescienceleader.com

Investments in #biotech companies reached their peak in 2020-21 but will this trend last? Don’t miss today's #virtual @demycolton event on #fundraising strategies for EU #Biopharma companies, featuring our clients AgomAb & @ITM_AG. Click: https://t.co/o46oEtHOjp

Load More...